These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32120775)

  • 1. Cyclooxygenases Inhibitors Efficiently Induce Cardiomyogenesis in Human Pluripotent Stem Cells.
    Nemade H; Acharya A; Chaudhari U; Nembo E; Nguemo F; Riet N; Abken H; Hescheler J; Papadopoulos S; Sachinidis A
    Cells; 2020 Feb; 9(3):. PubMed ID: 32120775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBIO Does Not Induce Cardiomyogenesis in Human Pluripotent Stem Cells but Modulates Cardiac Subtype Enrichment by Lineage-Selective Survival.
    Jara-Avaca M; Kempf H; Rückert M; Robles-Diaz D; Franke A; de la Roche J; Fischer M; Malan D; Sasse P; Solodenko W; Dräger G; Kirschning A; Martin U; Zweigerdt R
    Stem Cell Reports; 2017 Feb; 8(2):305-317. PubMed ID: 28089668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes.
    Zhao Q; Wang X; Wang S; Song Z; Wang J; Ma J
    Stem Cell Res Ther; 2017 Mar; 8(1):54. PubMed ID: 28279214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells.
    Ren Y; Lee MY; Schliffke S; Paavola J; Amos PJ; Ge X; Ye M; Zhu S; Senyei G; Lum L; Ehrlich BE; Qyang Y
    J Mol Cell Cardiol; 2011 Sep; 51(3):280-7. PubMed ID: 21569778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the Inconsistencies of Cardiac Differentiation Efficiency Induced by the GSK3β Inhibitor CHIR99021 in Human Pluripotent Stem Cells.
    Laco F; Woo TL; Zhong Q; Szmyd R; Ting S; Khan FJ; Chai CLL; Reuveny S; Chen A; Oh S
    Stem Cell Reports; 2018 Jun; 10(6):1851-1866. PubMed ID: 29706502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
    Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
    Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Priming of Human Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Accelerates Cardiomyocyte Maturation.
    Biermann M; Cai W; Lang D; Hermsen J; Profio L; Zhou Y; Czirok A; Isai DG; Napiwocki BN; Rodriguez AM; Brown ME; Woon MT; Shao A; Han T; Park D; Hacker TA; Crone WC; Burlingham WJ; Glukhov AV; Ge Y; Kamp TJ
    Stem Cells; 2019 Jul; 37(7):910-923. PubMed ID: 31087611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust Generation of Cardiomyocytes from Human iPS Cells Requires Precise Modulation of BMP and WNT Signaling.
    Kadari A; Mekala S; Wagner N; Malan D; Köth J; Doll K; Stappert L; Eckert D; Peitz M; Matthes J; Sasse P; Herzig S; Brüstle O; Ergün S; Edenhofer F
    Stem Cell Rev Rep; 2015 Aug; 11(4):560-9. PubMed ID: 25392050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional expression and pharmaceutical efficacy of cardiac-specific ion channels in human embryonic stem cell-derived cardiomyocytes.
    Kim HS; Yoon JW; Li H; Jeong GO; Park JJ; Shin SE; Jang IH; Kim JH; Park WS
    Sci Rep; 2017 Oct; 7(1):13821. PubMed ID: 29062050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of small molecule-induced cardiomyocytes from human induced pluripotent stem cells using a reporter system.
    Hwang GH; Park SM; Han HJ; Kim JS; Yun SP; Ryu JM; Lee HJ; Chang W; Lee SJ; Choi JH; Choi JS; Lee MY
    J Cell Physiol; 2017 Dec; 232(12):3384-3395. PubMed ID: 28063225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin Promotes Cardiac Differentiation of Human Pluripotent Stem Cells in Chemically Defined Albumin-Free Medium, Enabling Consistent Manufacture of Cardiomyocytes.
    Lin Y; Linask KL; Mallon B; Johnson K; Klein M; Beers J; Xie W; Du Y; Liu C; Lai Y; Zou J; Haigney M; Yang H; Rao M; Chen G
    Stem Cells Transl Med; 2017 Feb; 6(2):527-538. PubMed ID: 28191759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing Cardiovascular Drug Screening Using Human Pluripotent Stem Cell-Derived Cardiomyocytes.
    Oh J; Kwon OB; Park SW; Kim JW; Lee H; Kim YK; Choi EJ; Jung H; Choi DK; Oh BJ; Min SH
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional improvement and maturation of human cardiomyocytes derived from human pluripotent stem cells by barbaloin preconditioning.
    Yang H; Zhong W; Hamidi MR; Zhou G; Liu C
    Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(10):1041-1048. PubMed ID: 31518384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed cardiomyogenesis of human pluripotent stem cells by modulating Wnt/β-catenin and BMP signalling with small molecules.
    Aguilar JS; Begum AN; Alvarez J; Zhang XB; Hong Y; Hao J
    Biochem J; 2015 Jul; 469(2):235-41. PubMed ID: 26171831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-aging effects of vitamin C on human pluripotent stem cell-derived cardiomyocytes.
    Kim YY; Ku SY; Huh Y; Liu HC; Kim SH; Choi YM; Moon SY
    Age (Dordr); 2013 Oct; 35(5):1545-57. PubMed ID: 22843416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling cadmium-induced cardiotoxicity using human pluripotent stem cell-derived cardiomyocytes.
    Shen J; Wang X; Zhou D; Li T; Tang L; Gong T; Su J; Liang P
    J Cell Mol Med; 2018 Sep; 22(9):4221-4235. PubMed ID: 29993192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled Release of Small Molecules for Cardiac Differentiation of Pluripotent Stem Cells.
    Tsao CJ; Taraballi F; Pandolfi L; Velasquez-Mao AJ; Ruano R; Tasciotti E; Jacot JG
    Tissue Eng Part A; 2018 Dec; 24(23-24):1798-1807. PubMed ID: 30129882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin and CHIR99021 Coordinate Robust Cardiomyocyte Differentiation From Human Pluripotent Stem Cells Via Reducing p53-Dependent Apoptosis.
    Qiu XX; Liu Y; Zhang YF; Guan YN; Jia QQ; Wang C; Liang H; Li YQ; Yang HT; Qin YW; Huang S; Zhao XX; Jing Q
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells:
    Jiang Y; Park P; Hong SM; Ban K
    Mol Cells; 2018 Jul; 41(7):613-621. PubMed ID: 29890820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.